CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
15 01 2021
Historique:
received: 30 06 2020
accepted: 25 11 2020
entrez: 16 1 2021
pubmed: 17 1 2021
medline: 29 6 2021
Statut: epublish

Résumé

Central nervous system (CNS) involvement remains a challenge in the diagnosis and treatment of acute lymphoblastic leukemia (ALL). In this study, we identify CD79a (also known as Igα), a signaling component of the preB cell receptor (preBCR), to be associated with CNS-infiltration and -relapse in B-cell precursor (BCP)-ALL patients. Furthermore, we show that downregulation of CD79a hampers the engraftment of leukemia cells in different murine xenograft models, particularly in the CNS.

Identifiants

pubmed: 33452446
doi: 10.1038/s42003-020-01591-z
pii: 10.1038/s42003-020-01591-z
pmc: PMC7810877
doi:

Substances chimiques

CD79 Antigens 0
CD79A protein, human 0
src-Family Kinases EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

73

Références

Leukemia. 2003 Aug;17(8):1566-72
pubmed: 12886244
J Exp Med. 1994 Nov 1;180(5):1955-60
pubmed: 7964471
Nat Med. 2016 Apr;22(4):379-87
pubmed: 26974310
Leukemia. 2009 Aug;23(8):1406-9
pubmed: 19282835
Nat Rev Immunol. 2013 Aug;13(8):578-91
pubmed: 23883968
Blood. 2017 Aug 3;130(5):643-654
pubmed: 28550041
Leukemia. 2016 Jun;30(6):1246-54
pubmed: 26847027
Nature. 2018 Aug;560(7716):55-60
pubmed: 30022166
Blood. 2019 Aug 22;134(8):713-716
pubmed: 31311816
Leukemia. 2015 Jul;29(7):1578-86
pubmed: 25708834
Blood. 2016 Apr 21;127(16):1998-2006
pubmed: 26869395
Cancer Cell. 2015 Mar 9;27(3):409-25
pubmed: 25759025
Annu Rev Immunol. 2001;19:595-621
pubmed: 11244048
N Engl J Med. 2009 Jan 29;360(5):470-80
pubmed: 19129520
JAMA Oncol. 2018 Jul 12;4(7):e180089
pubmed: 29596541
Cancer Metastasis Rev. 2020 Mar;39(1):173-187
pubmed: 31970588
Blood. 2018 Oct 11;132(15):1614-1617
pubmed: 30154115
J Clin Oncol. 2007 Oct 20;25(30):4813-20
pubmed: 17947730
Lancet Oncol. 2008 Mar;9(3):257-68
pubmed: 18308251
Pediatr Blood Cancer. 2011 Oct;57(4):569-77
pubmed: 21360654
Haematologica. 2017 Feb;102(2):346-355
pubmed: 27686375
Blood. 2014 Nov 27;124(23):3420-30
pubmed: 25253770
Nat Rev Immunol. 2009 Mar;9(3):195-205
pubmed: 19240758
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13789-94
pubmed: 16940357
Blood. 2015 Jan 29;125(5):820-30
pubmed: 25428221

Auteurs

Lennart Lenk (L)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Michela Carlet (M)

Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Marchioninistraße 25, 81377, Munich, Germany.

Fotini Vogiatzi (F)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Lea Spory (L)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Dorothee Winterberg (D)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Antony Cousins (A)

Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1QH, UK.

Michaela Vossen-Gajcy (M)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Olta Ibruli (O)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Christian Vokuhl (C)

Department of Pathology, Section of Pediatric Pathology, Venusberg-Campus 1, Gebäude 62, 53127, Bonn, Germany.

Gunnar Cario (G)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Omar El Ayoubi (O)

Institute of Immunology, Ulm University Medical Center, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Lisa Kramer (L)

Institute of Immunology, Ulm University Medical Center, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Matthias Ritgen (M)

Department of Medicine II, University Hospital Schleswig-Holstein, Langer Segen 8-10, 24105, Kiel, Germany.

Monika Brüggemann (M)

Department of Medicine II, University Hospital Schleswig-Holstein, Langer Segen 8-10, 24105, Kiel, Germany.

Robert Häsler (R)

Institute of Clinical Molecular Biology, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.

Martin Schrappe (M)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany.

Stephan Fuhrmann (S)

Department of Hematology and Oncology, HELIOS Hospital Berlin-Buch, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.

Christina Halsey (C)

Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1QH, UK.

Irmela Jeremias (I)

Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Marchioninistraße 25, 81377, Munich, Germany.
German Cancer Consortium (DKTK), Partnering Site Munich, Pettenkoferstr. 8a, 80336, München, Germany.
Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Lindwurmstraße 4, 80337, München, Germany.

Elias Hobeika (E)

Institute of Immunology, Ulm University Medical Center, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Hassan Jumaa (H)

Institute of Immunology, Ulm University Medical Center, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Ameera Alsadeq (A)

Institute of Immunology, Ulm University Medical Center, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

Denis M Schewe (DM)

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Arnold-Heller-Str. 3, Haus C, 24105, Kiel, Germany. denis.schewe@uksh.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH